Radiocaine Safety Study (NCT07081217)
[18F]Radiocaine: Radiation and Radiochemical Safety
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-18-labeled PET radiotracer designed to bind voltage-gated sodium channels. The study enrolls adult volunteers and aims to inform future clinical development in molecular imaging applications. Radiocaine™ is being developed as a potential diagnostic imaging agent and imaging biomarker for the localization and quantification of sodium channel activity.
Who can join: Review the eligibility criteria below.
Location: Stanford University School of Medicine — Stanford, California
Age range: 18 Years
🧪 Interventions in This Study
- Intravenous Radiocaine (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stanford University School of Medicine — Stanford, California
📞 Contact the Study Coordinator
Phone: (877) 310-1326
Email: info@lutrooimaging.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Healthy Subjects
- Metabolic Responses to Spermidine Supplementation. — Addison, Illinois
- Lysine-specific Demethylase 1 and Salt-sensitivity in Humans — Boston, Massachusetts
- Effect of Stimulation on the Vagus Nerve — Indianapolis, Indiana
- Training Effects on Fuel Metabolism — Minneapolis, Minnesota
- Methemoglobin Concentration in High Dose Inhaled Nitric Oxide — Boston, Massachusetts
- Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan — Mountain View, California
Explore by condition: All Healthy Subjects clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.